Life Insurance to Fund a Buy‑Sell Agreement

Watch first

Instructional video

Josh Sterling teaches this strategy

In this walkthrough, Josh teaches the funding side of a buy‑sell end to end — cross‑purchase vs. entity‑owned vs. hybrid, the transfer‑for‑value rule that quietly turns a tax‑free benefit taxable, why an entity redemption can cost the survivor a basis step‑up, and how to keep the policy funding and the agreement's valuation language synchronized as the business grows.

The full picture

What it is

A buy‑sell agreement is the contract that governs what happens to a closely held business when an owner dies, becomes disabled, retires, or otherwise exits. It answers the legal questions: who can or must buy the departing owner's interest, at what price, and on what terms. What it almost never answers on its own is the financial question — where the money to fund that purchase actually comes from. Funding a buy‑sell with life insurance closes that gap. Policies are placed on each owner's life so that, at a triggering death, a tax‑free death benefit arrives in the exact amount needed to buy out that owner's interest. The agreement says what happens; the insurance makes it possible to happen.

The reason life insurance fits this job better than any alternative is timing and certainty. The need for cash is created by an event — a death — that also creates the death benefit. The two are perfectly correlated: the dollars show up precisely when the obligation is triggered, in full, regardless of what the business's cash position or credit looks like at that moment. No other funding method has that property. Sinking‑fund savings take years to build and tie up working capital the whole time. A bank loan after a key owner's death is expensive, slow, and often simply unavailable — the company just lost a principal and its risk profile spiked. Installment buyouts from future profits leave the deceased owner's family as a long‑term creditor of a business they no longer control. Life insurance funding is the only method that is fully funded from day one for the cost of an annual premium.

The structure also has to respect the tax code, because the headline benefit — the buyout dollars arrive income‑tax‑free — is true only when the policy ownership and the agreement are built correctly. Get the ownership structure wrong and a few specific traps (covered below) can pull the death benefit, or the gain on the policy, back into income. This is a strategy where the concept is simple and the structure is everything: the difference between a clean, tax‑free transfer and an expensive mess is entirely in how the policies are owned and how the agreement is drafted to match.

Who it's for

The ideal client is an owner of a privately held, operating business held with one or more co‑owners — two dentists, three siblings in a manufacturing company, a pair of founders in a professional firm, a handful of partners in a real estate operating entity. The defining features: the business is a meaningful share of each owner's net worth, the owners are not easily replaceable, and the business cannot simply be liquidated and split without destroying its value. There is usually a buy‑sell agreement already in place (or one being drafted) — these clients tend to be organized enough to have the legal documents and are simply missing the funding. They also need to be insurable and to have a business valuation large enough that the buyout obligation is real money: a $2M, $12M, or $50M company all need this, but the urgency scales with the number. Owners in their 40s through 60s, mid‑career, with families who depend on either the income or the eventual sale proceeds, are the heart of the profile. Disparities matter too — owners of very different ages or health profiles change which funding structure is cleanest.

When / why the problem actually shows up

The need surfaces at recognizable moments. A new partner is admitted and the operating agreement is updated — the perfect, and most overlooked, time to fund the buy‑sell that gets drafted alongside it. A business crosses a valuation threshold where the buyout obligation suddenly dwarfs anything the survivors could pay out of pocket. An owner's spouse asks the uncomfortable question — "if something happens to your partner, are we protected?" — and nobody has a good answer. An attorney finishes a buy‑sell and notes, almost in passing, that funding is "a separate conversation" that then never happens. A near‑miss — a health scare, a partner's heart attack — makes the abstract risk vivid overnight. Or a CPA preparing the business return realizes the company has no mechanism to generate buyout cash and no insurance behind the agreement on file. In every one of these the legal half is done; the financial half is exposed. The trigger for the advisor is almost always the same: an agreement exists, and no money stands behind it.

How it's structured

There are three core structures, and choosing among them is the heart of the work:

Cross‑purchase. Each owner personally buys and owns a policy on each other owner, and is the beneficiary. At a death, the surviving owner(s) receive the death benefit personally and use it to buy the deceased owner's interest directly from the estate. Cleanest for the survivors: they get a cost‑basis step‑up in the shares they purchase (the price paid becomes their new basis), which matters enormously on a later sale. The catch is policy count — with n owners you need n × (n−1) policies, which gets unwieldy past two or three owners, and premiums can be unequal if the owners differ sharply in age or health.

Entity‑owned (stock redemption). The business itself owns one policy per owner, pays the premiums, and is the beneficiary. At a death, the company collects the benefit and redeems (buys back) the deceased owner's shares from the estate. Far simpler administratively — one policy per owner, premiums paid by the entity. The trade‑offs: the surviving owners get no basis step‑up in the redeemed shares (the value flows up through the entity, not into their personal basis), C‑corporation death benefits can trigger the alternative minimum tax / corporate AMT considerations, and the proceeds may be exposed to business creditors.

Hybrid / wait‑and‑see. The agreement is drafted so the decision between cross‑purchase and redemption is deferred until the triggering event actually occurs — typically the entity holds an option to redeem first, with the surviving owners holding a backstop cross‑purchase right (or vice versa). This preserves flexibility to optimize for the basis step‑up and tax position based on the facts at the time, and is often the most defensible structure for multi‑owner companies. Specialized variants (e.g., an insurance LLC that holds the policies for a multi‑owner cross‑purchase) solve the policy‑count and transfer‑for‑value problems at once.

The money flow in all three is the same in spirit: premiums are paid during life (by the owners personally in a cross‑purchase, by the company in a redemption); at a triggering death the carrier pays the death benefit to the policy owner; that owner uses the cash to purchase the deceased's interest from the estate at the price the agreement specifies; the estate receives cash, the surviving structure receives the shares, and the business continues under the remaining owners. Two things must be kept synchronized for life: the coverage amount must track the business's growing valuation (a $6M policy against a stake now worth $10M leaves a $4M hole), and the agreement's valuation method (fixed price, formula, or appraisal) must be current and consistent with how the IRS will value the interest at death.

Red flags — what to look for

These are the observable signals in a real client situation that mean a life‑insurance‑funded buy‑sell may genuinely fit — and that the existing plan may be only half‑built.

A signed buy‑sell with no insurance behind it. The client proudly produces an attorney‑drafted agreement — and when you ask what funds it, the answer is "we'll figure it out" or "the business will cover it." That gap is the opportunity.
The "where would the money come from?" shrug. You ask, "If your partner died tomorrow, where do the buyout dollars come from?" and the owner pauses, shrugs, or says "a loan, I guess." That hesitation is the tell.
A business that has grown far past its last funding check. Coverage (or a fixed buyout price) was set years ago at a fraction of today's value — a $4M policy or a $4M agreed price against an interest now worth $11M. The plan is stale and badly underfunded.
Owners of very different ages or health. A 58‑year‑old partner and a 41‑year‑old partner, or one owner with a health condition — the situation where a naive equal‑policy cross‑purchase produces wildly unequal premiums and someone quietly stops paying.
A spouse or heir who would inherit the shares. The deceased owner's stock would pass to a spouse or child with no role in or knowledge of the business — the classic "now I co‑own a company with my late partner's widow" exposure the survivors dread.
A C corporation with an entity‑owned policy already in place. The structure exists but may be carrying avoidable tax exposure (lost basis step‑up, corporate AMT, creditor reach) — a candidate for a hybrid restructure rather than a new policy.
A buy‑sell that was funded but never updated after an ownership change. A partner was added, bought out, or changed percentage, and the policies and agreement never caught up — the funding now points at the wrong people in the wrong amounts.

Common pitfalls

The transfer‑for‑value trap. This is the one that quietly destroys the tax benefit. If an existing policy is transferred for value (e.g., owners swap personally owned policies to convert from an entity structure to a cross‑purchase, or a new partner buys into existing coverage), the death benefit can lose its income‑tax‑free status and become taxable to the extent it exceeds basis. Always check whether any policy is changing hands for consideration, and use a recognized exception (transfer to the insured, to a partner of the insured, to a partnership in which the insured is a partner) — this is precisely why an insurance‑LLC structure exists for multi‑owner cross‑purchases.
Choosing the structure for convenience instead of for basis. Defaulting to entity‑owned because it's "simpler" can cost the surviving owners a cost‑basis step‑up worth a fortune on a later sale of the business. The simpler structure is not always the cheaper one — run the after‑tax outcome on a hypothetical later exit before deciding.
Coverage that never tracks valuation. Policies and agreed prices set at founding and never revisited. The business triples in value and the funding covers a third of the obligation, leaving the survivors to find the rest in cash anyway. Build a periodic review (and ideally a valuation formula in the agreement) so the coverage scales with the company.
The agreement and the policies disagreeing. The buy‑sell names a price or formula; the insurance was sized to a different number; the ownership of the policies doesn't match the structure the agreement assumes. When the documents and the funding don't reconcile, the survivors inherit a dispute at the worst possible moment.
C‑corporation alternative‑minimum‑tax surprise. A C corp collecting a large death benefit on an entity‑owned policy can face corporate AMT exposure, eroding the very liquidity the plan was meant to deliver. Model it, and consider whether a cross‑purchase or hybrid sidesteps the issue.
Funding death but ignoring disability and other triggers. A buy‑sell is usually triggered by more than death — disability, retirement, divorce, bankruptcy. Life insurance solves the death trigger cleanly; the other triggers need their own funding answer (e.g., disability buyout coverage, a sinking fund, or installment terms). Don't let "we funded the buy‑sell" mean only the death scenario.

Client example

The client. Two partners, both in their early 50s, owned a $12M operating business 50/50 — a company they'd built together over twenty years and that represented the largest asset on each of their balance sheets. Years earlier, their attorney had drafted a clean buy‑sell agreement: at a partner's death, the survivor had the obligation to buy the deceased's 50% interest from the estate at an appraised value. It was a good document. It was completely unfunded. Their financial advisor — a planner who'd handled their personal portfolios for years — asked the question at a review: "If one of you died tomorrow, where does the other find $6M to buy out the family?" Neither had an answer. The honest plan was "take out a loan," which, after the death of half the company's leadership, was wishful thinking.

The trigger. One partner had a cardiac scare that put him in the hospital for a week. He recovered fully, but the near‑miss made the abstract risk concrete for both families overnight. The surviving‑spouse conversation — would I be forced to co‑own this business, or fight for a fair price? — was suddenly real. That was the moment the advisor moved the funding from "someday" to "now."

The structure. We implemented a cross‑purchase: each partner personally bought a $6M policy on the other, matching each 50% interest, with the agreement updated to use a current appraisal formula so the funding and the price would stay in step as the business grew. We chose cross‑purchase deliberately over an entity redemption so that the surviving partner would receive a cost‑basis step‑up in the purchased shares — materially lowering the tax on the eventual sale of the company they fully expected to happen within a decade. We confirmed there was no transfer‑for‑value issue (both policies were newly issued, owner‑on‑partner), and we built a calendar reminder to re‑test the valuation and coverage every two to three years.

The outcome. The agreement now has the one thing it always lacked: the money. If either partner dies, the survivor receives $6M tax‑free, buys out the family cleanly at the appraised price, and keeps running the business on day one — no bank, no asset sale, no grieving spouse in the boardroom, no valuation fight. Both families are protected on equal terms. And the advisor who asked the uncomfortable question turned a binder full of legal paper into a plan that actually works — and earned the estate, tax, and eventual‑sale planning that naturally followed.

The advisor angle

A signed buy‑sell agreement tends to close the subject, which is exactly why the funding half so often goes unexamined. The document decides who buys and at what price; it does not produce the money. The question that surfaces the gap is a simple one — "where would the buyout money actually come from?" — and it is worth asking even when the agreement itself is well drafted.

The deeper win is positional. A funded buy‑sell sits at the intersection of business succession, tax structure, estate planning, and family protection⁠—⁠disciplines often handled by different professionals, where each piece can look complete on its own. Raising it with the buy‑sell attorney they already have puts the financial half of the agreement on the table alongside the legal half. That's the Unified premise in action: complex wealth creates complex decisions, and fragmented advice makes them harder. You don't have to be the buy‑sell funding expert yourself. You have to be the advisor who recognized the half‑built plan and brought in the strategist to finish it right — which is exactly the role that keeps you at the center of the planning while the specialized work gets done properly.

Strategy descriptions are educational and general in nature. Tax, legal and estate outcomes depend on how a strategy is structured and on each client's own facts; the results described here assume the strategy is properly structured and applicable requirements are met. Confirm current law and individual circumstances before acting.